Artificial intelligence could be a big differentiator for Hims & Hers.

Threat actors breached the telehealth brand, and now they may know who's bald, overweight, and impotent. What could they do ...

Bank of America lowered its 2026 price target for Hims & Hers (NYSE:HIMS) to $21 from $23, citing peer multiple compression ...

Hims is making GLP‑1 weight loss more accessible for men with a new membership starting at $39 for the first month. Here’s ...

Hims & Hers (HIMS) stock fell 39% in 2026 after shifting to branded GLP-1 drugs. Amazon's Foundayo launch adds pressure.

Hims & Hers is changing that reality. Through a digital-first, proactive model, life-changing care can belong to everyone, ...

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it ...

SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is actively investigating data privacy claims arising from the Hims & Hers, Inc. data breach. On ...

The Danish drugmaker sued Hims in February over compounded versions of the Wegovy weight-loss pill that Hims launched and ...

Check out the latest Hims & Hers Health Inc (HIMS) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including ...

Thu, March 12, 2026 at 2:46 PM UTC Then came the surprise truce announced last Friday: Novo dropped the lawsuit (while reserving the right to refile), and Hims agreed to sell branded Wegovy and ...